Page 12 - ஷாங்காய் ஸ்டாக் பரிமாற்றம் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article SHANGHAI, Dec. 22, 2020 /PRNewswire/ 111, Inc. ( 111 or the Company ) (NASDAQ: YI), a leading digital healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced the successful completion of new capital injection in its principal PRC subsidiary by a selected group of strategic and mission-driven investors. On December 22, 2020, 1 Pharmacy Yaofang Technology (Shanghai) Co., Ltd. (previously known as Yao Fang Information Technology (Shanghai) Co., Ltd.) ( Yao Fang Shanghai ), the principal operating subsidiary of 111 in China, completed a new round of capital injection from strategic investors. According to the investment agreements, the investors invested in Yao Fang Shanghai an aggregate of RMB515 million (approximately US$78.75 million

Yao fangYao wangShen liJunling liuZhangjiang technology venture investmentHuasai fundYao wang corporationExchange commissionShanghai strategy fundStrategic communicationsPharmacy yaofang technology shanghai co ltdSecurities exchangeShanghai stock exchange sciShanghai science technology venture capitalYaofang technologyYao fang information technology